RecallDepth
Class I Terminated

Tydemy (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets 0.451 mg), packaged in 1 blister of 28 tablets each (NDC 68180-904-71) further packaged in a carton of 3 blisters (NDC 68180-904-73), Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by Lupin Limited, Pithampur (M.P.), INDIA

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
June 23, 2023
Posted
August 9, 2023
Recall Number
D-1081-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4,179 boxes/_ cartons per box/3 pouches each/28 blister per pouch
Firm Location
Baltimore, MD, United States

Reason for Recall

Failed Stability Specification and Failed Impurities/Degradation Specifications: out of specification for inactive content ascorbic acid and MTHFRC-7impurity test

Distribution

USA nationwide.

Lot / Code Info

Lot #: L200183, Exp 1/2024; L201560, Exp 9/2024

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class I Drug recalls